Danielle Hunt

Danielle Hunt is an experienced strategic oncology drug developer and people leader currently serving as the Asset Strategy Leader for Oncology at AbbVie. From 2021 to 2024, they held the position of Senior Director of Clinical Study Leadership Oncology at the same company. Danielle began their career in research at Genitope Corporation from 2002 to 2004, developing hybridomas and monoclonal antibodies. They further honed their expertise in oncology through various roles at Genentech, where they were involved in global studies and program management. Danielle earned a B.S. in Biology from the University at Albany, SUNY, in 2001.